These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16007223

  • 1. The merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.
    Ryu CH, Kim SW, Lee KH, Lee JY, Kim H, Lee WK, Choi BH, Lim Y, Kim YH, Lee KH, Hwang TK, Jun TY, Rha HK.
    Oncogene; 2005 Aug 11; 24(34):5355-64. PubMed ID: 16007223
    [Abstract] [Full Text] [Related]

  • 2. MAP, a protein interacting with a tumor suppressor, merlin, through the run domain.
    Lee IK, Kim KS, Kim H, Lee JY, Ryu CH, Chun HJ, Lee KU, Lim Y, Kim YH, Huh PW, Lee KH, Han SI, Jun TY, Rha HK.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):774-83. PubMed ID: 15541357
    [Abstract] [Full Text] [Related]

  • 3. Plasma membrane recruitment of RalGDS is critical for Ras-dependent Ral activation.
    Matsubara K, Kishida S, Matsuura Y, Kitayama H, Noda M, Kikuchi A.
    Oncogene; 1999 Feb 11; 18(6):1303-12. PubMed ID: 10022812
    [Abstract] [Full Text] [Related]

  • 4. Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.
    Tsukamoto S, Ihara R, Aizawa A, Kishida S, Kikuchi A, Imai H, Minami N.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1105-12. PubMed ID: 16580637
    [Abstract] [Full Text] [Related]

  • 5. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
    Lim JY, Kim H, Jeun SS, Kang SG, Lee KJ.
    Biochem Biophys Res Commun; 2006 Feb 24; 340(4):1151-7. PubMed ID: 16405865
    [Abstract] [Full Text] [Related]

  • 6. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T, Grönholm M, Lampin A, Lallemand D, Zhao F, Giovannini M, Carpén O.
    Hum Mol Genet; 2007 Jul 15; 16(14):1742-51. PubMed ID: 17566081
    [Abstract] [Full Text] [Related]

  • 7. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.
    Xu J, Shi S, Matsumoto N, Noda M, Kitayama H.
    Cell Signal; 2007 Jul 15; 19(7):1575-82. PubMed ID: 17382517
    [Abstract] [Full Text] [Related]

  • 8. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator.
    Kishida S, Koyama S, Matsubara K, Kishida M, Matsuura Y, Kikuchi A.
    Oncogene; 1997 Dec 11; 15(24):2899-907. PubMed ID: 9416833
    [Abstract] [Full Text] [Related]

  • 9. [Neurofibromatosis type 2 (NF2)].
    Araki N, Takeshima H, Saya H.
    Gan To Kagaku Ryoho; 1997 Sep 11; 24(11):1427-31. PubMed ID: 9309136
    [Abstract] [Full Text] [Related]

  • 10. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P.
    Cancer Res; 2007 Jan 15; 67(2):520-7. PubMed ID: 17234759
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR, Huynh DP, Morcos PA, Coulsell ER, Robinson NG, Tamanoi F, Pulst SM.
    Nat Genet; 1998 Apr 15; 18(4):354-9. PubMed ID: 9537418
    [Abstract] [Full Text] [Related]

  • 13. Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.
    Chen Y, Gutmann DH, Haipek CA, Martinsen BJ, Bronner-Fraser M, Krull CE.
    Dev Dyn; 2004 Mar 15; 229(3):541-54. PubMed ID: 14991710
    [Abstract] [Full Text] [Related]

  • 14. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC, Kissil JL, Fry JL, Jacks T.
    Oncogene; 2002 Sep 05; 21(39):5990-7. PubMed ID: 12203111
    [Abstract] [Full Text] [Related]

  • 15. Neurofibromatosis 2 tumor suppressor, the gene induced by valproic acid, mediates neurite outgrowth through interaction with paxillin.
    Yamauchi J, Miyamoto Y, Kusakawa S, Torii T, Mizutani R, Sanbe A, Nakajima H, Kiyokawa N, Tanoue A.
    Exp Cell Res; 2008 Jul 01; 314(11-12):2279-88. PubMed ID: 18486129
    [Abstract] [Full Text] [Related]

  • 16. Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c).
    Scoles DR, Yong WH, Qin Y, Wawrowsky K, Pulst SM.
    Hum Mol Genet; 2006 Apr 01; 15(7):1059-70. PubMed ID: 16497727
    [Abstract] [Full Text] [Related]

  • 17. Interdomain binding mediates tumor growth suppression by the NF2 gene product.
    Sherman L, Xu HM, Geist RT, Saporito-Irwin S, Howells N, Ponta H, Herrlich P, Gutmann DH.
    Oncogene; 1997 Nov 13; 15(20):2505-9. PubMed ID: 9395247
    [Abstract] [Full Text] [Related]

  • 18. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T, Lee MF, James M, Neujahr R, Smith N, Murthy A, Hartwig J, Gusella JF, Ramesh V.
    Oncogene; 2004 Nov 18; 23(54):8815-25. PubMed ID: 15467741
    [Abstract] [Full Text] [Related]

  • 19. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor.
    López-Barahona M, Bustelo XR, Barbacid M.
    Oncogene; 1996 Feb 01; 12(3):463-70. PubMed ID: 8637701
    [Abstract] [Full Text] [Related]

  • 20. Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation.
    Tang X, Jang SW, Wang X, Liu Z, Bahr SM, Sun SY, Brat D, Gutmann DH, Ye K.
    Nat Cell Biol; 2007 Oct 01; 9(10):1199-207. PubMed ID: 17891137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.